GLIOMA, MALIGNANT
Clinical trials for GLIOMA, MALIGNANT explained in plain language.
Never miss a new study
Get alerted when new GLIOMA, MALIGNANT trials appear
Sign up with your email to follow new studies for GLIOMA, MALIGNANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted antibody may boost brain cancer treatment after incomplete surgery
Disease control Not yet recruitingThis phase 2 trial tests whether adding nimotuzumab—an antibody that blocks a protein called EGFR—to the standard Stupp regimen (temozolomide plus radiotherapy) can improve outcomes for adults with glioblastoma that was not fully removed by surgery. Participants must have EGFR-po…
Matched conditions: GLIOMA, MALIGNANT
Phase: PHASE2 • Sponsor: Tianjin First Central Hospital • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Cold war on brain cancer: herpes virus injected into tumors in new trial
Disease control Not yet recruitingThis early-stage trial tests a modified herpes virus (C5252) injected directly into the brain tumor cavity of 36 adults with recurrent high-grade glioma who have run out of standard options. The goal is to see if the virus is safe and can help control the disease. Participants wi…
Matched conditions: GLIOMA, MALIGNANT
Phase: PHASE1, PHASE2 • Sponsor: ImmVira Pharma Co. Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC